Indications
Therapeutic Asset Ratings
3,272 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Ceralasertib
Uterine Corpus Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Bile Duct Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Carcinoma Of Esophagus
National Cancer Institute (NCI)
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Head And Neck Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Penile Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Distal Biliary Tract Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Intrahepatic Bile Duct Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Penile Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Cobimetinib
Endometrial Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Cobimetinib
Fallopian Tube Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Cobimetinib
Uterine Corpus Endometrial Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Cobimetinib
Uterine Corpus Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Copanlisib
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
National Cancer Institute (NCI)
P1
CC
(43)
Copanlisib
Hormone Receptor-Positive Breast Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Copanlisib
T-Cell/Histiocyte Rich Large B Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Cyclophosphamide
Neuroendocrine Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Cyclophosphamide
Human T-Lymphotropic Virus 1 Infectious Disease
National Cancer Institute (NCI)
P1
CC
(43)
Cyclophosphamide
Neoplasm Of Mature T-Cells Or NK-Cells
National Cancer Institute (NCI)
P1
CC
(43)
Cyclophosphamide
Thymus Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Cytarabine
Therapy-Related Myeloid Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Daunomycin
Acute Myeloid Leukemia, MLL Gene Rearrangement
National Cancer Institute (NCI)
P1
CC
(43)
Diphenhydramine
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)
P1
CC
(43)
Duvelisib
Adult T-Cell Leukemia/Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Duvelisib
Extranodal Nasal NK/T Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Duvelisib
Hepatosplenic T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Showing 2776 to 2800 of 3,272 assets
Previous
Page 112 of 131
Next